# | Title | Journal | Year | Citations |
---|
1 | Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases | Journal of Experimental Medicine | 2008 | 425 |
2 | Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force | Annals of the Rheumatic Diseases | 2014 | 397 |
3 | Randomized double‐blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) versus placebo in active spondylarthropathy | Arthritis and Rheumatism | 2002 | 374 |
4 | How Cytokine Networks Fuel Inflammation: Toward a cytokine-based disease taxonomy | Nature Medicine | 2013 | 341 |
5 | Meniscal allograft transplantation: long-term clinical results with radiological and magnetic resonance imaging correlations | Knee Surgery, Sports Traumatology, Arthroscopy | 2006 | 331 |
6 | Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group | Annals of the Rheumatic Diseases | 2011 | 330 |
7 | EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT | Annals of the Rheumatic Diseases | 2009 | 324 |
8 | Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study | Annals of the Rheumatic Diseases | 2000 | 267 |
9 | Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations | Annals of the Rheumatic Diseases | 2004 | 259 |
10 | Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial | Lancet, The | 2018 | 251 |
11 | A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis | Nature Genetics | 2011 | 250 |
12 | Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model | Annals of the Rheumatic Diseases | 2013 | 230 |
13 | Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative | Annals of the Rheumatic Diseases | 2014 | 222 |
14 | Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis | Arthritis Research | 2005 | 218 |
15 | Immunomodulatory effects of anti-tumor necrosis factor ? therapy on synovium in spondylarthropathy: Histologic findings in eight patients from an open-label pilot study | Arthritis and Rheumatism | 2001 | 210 |
16 | Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study | Annals of the Rheumatic Diseases | 2010 | 193 |
17 | Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice | Blood | 2012 | 189 |
18 | Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study | Annals of the Rheumatic Diseases | 2016 | 188 |
19 | Ankylosing spondylitis and bowel disease | Best Practice and Research in Clinical Rheumatology | 2006 | 187 |
20 | Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: Relevance to antifilaggrin autoantibodies | Arthritis and Rheumatism | 2001 | 177 |
21 | Vaccinations in patients with immune-mediated inflammatory diseases | Rheumatology | 2010 | 176 |
22 | Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy | Journal of Pathology | 2002 | 171 |
23 | Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: Biologic and clinical implications in autoimmune arthritis | Arthritis and Rheumatism | 2005 | 167 |
24 | Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery | Rheumatology | 2010 | 165 |
25 | How to perform and interpret capillaroscopy | Best Practice and Research in Clinical Rheumatology | 2013 | 163 |
26 | Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease? | Annals of the Rheumatic Diseases | 2003 | 159 |
27 | Autologous matrix-induced chondrogenesis combined with platelet-rich plasma gel: technical description and a five pilot patients report | Knee Surgery, Sports Traumatology, Arthroscopy | 2011 | 154 |
28 | The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects | Journal of Rheumatology | 1995 | 150 |
29 | A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement | Respiratory Research | 2018 | 149 |
30 | Human cartilage gp‐39+,CD16+ monocytes in peripheral blood and synovium: Correlation with joint destruction in rheumatoid arthritis | Arthritis and Rheumatism | 2000 | 148 |
31 | European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes | Journal of the European Academy of Dermatology and Venereology | 2017 | 148 |
32 | Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study | Annals of the Rheumatic Diseases | 2012 | 146 |
33 | Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus | Annals of the Rheumatic Diseases | 2009 | 143 |
34 | The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint | Journal of Rheumatology | 1995 | 136 |
35 | LTβR Signaling Induces Cytokine Expression and Up-Regulates Lymphangiogenic Factors in Lymph Node Anlagen | Journal of Immunology | 2009 | 135 |
36 | Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition | Journal of Rheumatology | 1990 | 134 |
37 | Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus | Annals of the Rheumatic Diseases | 2004 | 133 |
38 | Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre study | Annals of the Rheumatic Diseases | 2010 | 132 |
39 | Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy | Arthritis Research | 2005 | 127 |
40 | Degree of bone marrow oedema in sacroiliac joints of patients with axial spondyloarthritis is linked to gut inflammation and male sex: results from the GIANT cohort | Annals of the Rheumatic Diseases | 2014 | 126 |
41 | A Plant-Derived Ligand Favoring Monomeric Glucocorticoid Receptor Conformation with Impaired Transactivation Potential Attenuates Collagen-Induced Arthritis | Journal of Immunology | 2008 | 125 |
42 | Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis | Annals of the Rheumatic Diseases | 2010 | 125 |
43 | Design and conduct of clinical trials in patients with osteoarthritis of the hand: recommendations from a task force of the Osteoarthritis Research Society International | Osteoarthritis and Cartilage | 2006 | 123 |
44 | How the microbiota shapes rheumatic diseases | Nature Reviews Rheumatology | 2016 | 122 |
45 | Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis | Annals of the Rheumatic Diseases | 2005 | 121 |
46 | An EULAR study group pilot study on reliability of simple capillaroscopic definitions to describe capillary morphology in rheumatic diseases | Rheumatology | 2016 | 121 |
47 | Fibrin Deimination in Synovial Tissue Is Not Specific for Rheumatoid Arthritis but Commonly Occurs during Synovitides | Journal of Immunology | 2005 | 118 |
48 | Targeting inflammation using selective glucocorticoid receptor modulators | Current Opinion in Pharmacology | 2010 | 115 |
49 | Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis | Annals of the Rheumatic Diseases | 2019 | 115 |
50 | Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial | Annals of the Rheumatic Diseases | 2018 | 113 |